Literature DB >> 24327718

Targeting resistance in lung cancer.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24327718     DOI: 10.1158/2159-8290.CD-ND2013-025

Source DB:  PubMed          Journal:  Cancer Discov        ISSN: 2159-8274            Impact factor:   39.397


× No keyword cloud information.
  7 in total

1.  Noninvasive saliva-based EGFR gene mutation detection in patients with lung cancer.

Authors:  Fang Wei; Chien-Chung Lin; Aron Joon; Ziding Feng; Gabriel Troche; Maruja E Lira; David Chia; Mao Mao; Chung-Liang Ho; Wu-Chou Su; David T W Wong
Journal:  Am J Respir Crit Care Med       Date:  2014-11-15       Impact factor: 21.405

2.  Experience with afatinib in patients with non-small cell lung cancer progressing after clinical benefit from gefitinib and erlotinib.

Authors:  Martin Schuler; Jürgen R Fischer; Christian Grohé; Sylvia Gütz; Michael Thomas; Martin Kimmich; Claus-Peter Schneider; Eckart Laack; Angela Märten
Journal:  Oncologist       Date:  2014-09-17

3.  Quantification and dynamic monitoring of EGFR T790M in plasma cell-free DNA by digital PCR for prognosis of EGFR-TKI treatment in advanced NSCLC.

Authors:  Zhijie Wang; Rui Chen; Shuhang Wang; Jia Zhong; Meina Wu; Jun Zhao; Jianchun Duan; Minglei Zhuo; Tongtong An; Yuyan Wang; Hua Bai; Jie Wang
Journal:  PLoS One       Date:  2014-11-18       Impact factor: 3.240

Review 4.  Systemic treatment in EGFR-ALK NSCLC patients: second line therapy and beyond.

Authors:  Niki Karachaliou; Rafael Rosell
Journal:  Cancer Biol Med       Date:  2014-09       Impact factor: 4.248

Review 5.  Epidermal growth factor receptor (EGFR) mutations in lung cancer: preclinical and clinical data.

Authors:  S E D C Jorge; S S Kobayashi; D B Costa
Journal:  Braz J Med Biol Res       Date:  2014-09-05       Impact factor: 2.590

Review 6.  Targeted treatment of mutated EGFR-expressing non-small-cell lung cancer: focus on erlotinib with companion diagnostics.

Authors:  Niki Karachaliou; Rafael Rosell
Journal:  Lung Cancer (Auckl)       Date:  2014-11-13

Review 7.  The Emergent Landscape of Detecting EGFR Mutations Using Circulating Tumor DNA in Lung Cancer.

Authors:  Wei-Lun Huang; Fang Wei; David T Wong; Chien-Chung Lin; Wu-Chou Su
Journal:  Biomed Res Int       Date:  2015-09-13       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.